GlassScriptPhysician profile
Connie J Terrell
NPI 1932502218
$10,849.11
in general payments reported to CMS, 2019-2025
36 companies · $665 in 2025
The $665 reported for 2025 was more than what 80% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,231 · 2022: $1,803 · 2023: $4,240 · 2024: $2,909 · 2025: $665.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,648 · Travel and Lodging: $1,112 · Education: $54.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,648.42 |
| Travel and Lodging | $1,112.18 |
| Education | $54.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,155.83 | 2021-2025 | Wavewriter Alpha Prime 16, General - Pain Management |
| Medtronic, INC. | $2,142.10 | 2021-2024 | Synchromedii, Vanta Adaptivestim, Intellis Adaptivestim |
| Abbott Laboratories | $1,026.73 | 2021-2025 | Eterna |
| Abbvie INC. | $1,006.72 | 2021-2025 | |
| Nevro Corp. | $520.66 | 2022-2024 | Senza |
| Collegium Pharmaceutical, INC. | $503.45 | 2021-2025 | Belbuca, Xtampza |
| Protega Pharmaceutials INC | $402.31 | 2022-2023 | Roxybond |
| Relievant Medsystems, INC. | $301.59 | 2023 | Intracept |
| Scilex Pharmaceuticals INC. | $293.04 | 2021-2024 | Ztlido |
| Saluda Medical Americas, INC. | $292.51 | 2024-2025 | Evoke |
| Nalu Medical, INC. | $225.74 | 2022-2023 | Nalu Neurostimulation System |
| Biohaven Pharmaceuticals, INC. | $207.62 | 2021 | |
| Pfizer INC. | $160.73 | 2021-2024 | |
| Tersera Therapeutics LLC | $160.33 | 2021-2025 | Prialt |
| Vertos Medical, INC. | $155.27 | 2022-2024 | Mild Device Kit |
Show all 36 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Connie Terrell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.